Interaction between bone and muscle in older persons with mobility limitations

L. Ferrucci, M. Baroni, A. Ranchelli, F. Lauretani, M. Maggio, P. Mecocci, C. Ruggiero

Research output: Contribution to journalArticle

Abstract

Aging is associated with a progressive loss of bone-muscle mass and strength. When the decline in mass and strength reaches critical thresholds associated with adverse health outcomes, they are operationally considered geriatric conditions and named, respectively, osteoporosis and sarcopenia. Osteoporosis and sarcopenia share many of the same risk factors and both directly or indirectly cause higher risk of mobility limitations, falls, fractures and disability in activities of daily living. This is not surprising since bones adapt their morphology and strength to the long-term loads exerted by muscle during anti-gravitational and physical activities. Non-mechanical systemic and local factors also modulate the mechanostat effect of muscle on bone by affecting the bidirectional osteocyte-muscle crosstalk, but the specific pathways that regulate these homeostatic mechanisms are not fully understood. More research is required to reach a consensus on cut points in bone and muscle parameters that identify individuals at high risk for adverse health outcomes, including falls, fractures and disability. A better understanding of the muscle-bone physiological interaction may help to develop preventive strategies that reduce the burden of musculoskeletal diseases, the consequent disability in older persons and to limit the financial burden associated with such conditions. In this review, we summarize age-related bone-muscle changes focusing on the biomechanical and homeostatic mechanisms that explain bone-muscle interaction and we speculate about possible pathological events that occur when these mechanisms become impaired. We also report some recent definitions of osteoporosis and sarcopenia that have emerged in the literature and their implications in clinical practice. Finally, we outline the current evidence for the efficacy of available anti-osteoporotic and proposed antisarcopenic interventions in older persons.

Original languageEnglish (US)
Pages (from-to)3178-3197
Number of pages20
JournalCurrent Pharmaceutical Design
Volume20
Issue number19
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Mobility Limitation
Bone and Bones
Muscles
Sarcopenia
Osteoporosis
Musculoskeletal Diseases
Osteocytes
Health
Muscle Strength
Activities of Daily Living
Geriatrics
Research

Keywords

  • Aging
  • Bone-muscle
  • Disability
  • Osteoporosis
  • Sarcopenia

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Medicine(all)

Cite this

Ferrucci, L., Baroni, M., Ranchelli, A., Lauretani, F., Maggio, M., Mecocci, P., & Ruggiero, C. (2014). Interaction between bone and muscle in older persons with mobility limitations. Current Pharmaceutical Design, 20(19), 3178-3197. https://doi.org/10.2174/13816128113196660690

Interaction between bone and muscle in older persons with mobility limitations. / Ferrucci, L.; Baroni, M.; Ranchelli, A.; Lauretani, F.; Maggio, M.; Mecocci, P.; Ruggiero, C.

In: Current Pharmaceutical Design, Vol. 20, No. 19, 2014, p. 3178-3197.

Research output: Contribution to journalArticle

Ferrucci, L, Baroni, M, Ranchelli, A, Lauretani, F, Maggio, M, Mecocci, P & Ruggiero, C 2014, 'Interaction between bone and muscle in older persons with mobility limitations', Current Pharmaceutical Design, vol. 20, no. 19, pp. 3178-3197. https://doi.org/10.2174/13816128113196660690
Ferrucci L, Baroni M, Ranchelli A, Lauretani F, Maggio M, Mecocci P et al. Interaction between bone and muscle in older persons with mobility limitations. Current Pharmaceutical Design. 2014;20(19):3178-3197. https://doi.org/10.2174/13816128113196660690
Ferrucci, L. ; Baroni, M. ; Ranchelli, A. ; Lauretani, F. ; Maggio, M. ; Mecocci, P. ; Ruggiero, C. / Interaction between bone and muscle in older persons with mobility limitations. In: Current Pharmaceutical Design. 2014 ; Vol. 20, No. 19. pp. 3178-3197.
@article{5e54766903d24963b8902a5bc789609a,
title = "Interaction between bone and muscle in older persons with mobility limitations",
abstract = "Aging is associated with a progressive loss of bone-muscle mass and strength. When the decline in mass and strength reaches critical thresholds associated with adverse health outcomes, they are operationally considered geriatric conditions and named, respectively, osteoporosis and sarcopenia. Osteoporosis and sarcopenia share many of the same risk factors and both directly or indirectly cause higher risk of mobility limitations, falls, fractures and disability in activities of daily living. This is not surprising since bones adapt their morphology and strength to the long-term loads exerted by muscle during anti-gravitational and physical activities. Non-mechanical systemic and local factors also modulate the mechanostat effect of muscle on bone by affecting the bidirectional osteocyte-muscle crosstalk, but the specific pathways that regulate these homeostatic mechanisms are not fully understood. More research is required to reach a consensus on cut points in bone and muscle parameters that identify individuals at high risk for adverse health outcomes, including falls, fractures and disability. A better understanding of the muscle-bone physiological interaction may help to develop preventive strategies that reduce the burden of musculoskeletal diseases, the consequent disability in older persons and to limit the financial burden associated with such conditions. In this review, we summarize age-related bone-muscle changes focusing on the biomechanical and homeostatic mechanisms that explain bone-muscle interaction and we speculate about possible pathological events that occur when these mechanisms become impaired. We also report some recent definitions of osteoporosis and sarcopenia that have emerged in the literature and their implications in clinical practice. Finally, we outline the current evidence for the efficacy of available anti-osteoporotic and proposed antisarcopenic interventions in older persons.",
keywords = "Aging, Bone-muscle, Disability, Osteoporosis, Sarcopenia",
author = "L. Ferrucci and M. Baroni and A. Ranchelli and F. Lauretani and M. Maggio and P. Mecocci and C. Ruggiero",
year = "2014",
doi = "10.2174/13816128113196660690",
language = "English (US)",
volume = "20",
pages = "3178--3197",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "19",

}

TY - JOUR

T1 - Interaction between bone and muscle in older persons with mobility limitations

AU - Ferrucci, L.

AU - Baroni, M.

AU - Ranchelli, A.

AU - Lauretani, F.

AU - Maggio, M.

AU - Mecocci, P.

AU - Ruggiero, C.

PY - 2014

Y1 - 2014

N2 - Aging is associated with a progressive loss of bone-muscle mass and strength. When the decline in mass and strength reaches critical thresholds associated with adverse health outcomes, they are operationally considered geriatric conditions and named, respectively, osteoporosis and sarcopenia. Osteoporosis and sarcopenia share many of the same risk factors and both directly or indirectly cause higher risk of mobility limitations, falls, fractures and disability in activities of daily living. This is not surprising since bones adapt their morphology and strength to the long-term loads exerted by muscle during anti-gravitational and physical activities. Non-mechanical systemic and local factors also modulate the mechanostat effect of muscle on bone by affecting the bidirectional osteocyte-muscle crosstalk, but the specific pathways that regulate these homeostatic mechanisms are not fully understood. More research is required to reach a consensus on cut points in bone and muscle parameters that identify individuals at high risk for adverse health outcomes, including falls, fractures and disability. A better understanding of the muscle-bone physiological interaction may help to develop preventive strategies that reduce the burden of musculoskeletal diseases, the consequent disability in older persons and to limit the financial burden associated with such conditions. In this review, we summarize age-related bone-muscle changes focusing on the biomechanical and homeostatic mechanisms that explain bone-muscle interaction and we speculate about possible pathological events that occur when these mechanisms become impaired. We also report some recent definitions of osteoporosis and sarcopenia that have emerged in the literature and their implications in clinical practice. Finally, we outline the current evidence for the efficacy of available anti-osteoporotic and proposed antisarcopenic interventions in older persons.

AB - Aging is associated with a progressive loss of bone-muscle mass and strength. When the decline in mass and strength reaches critical thresholds associated with adverse health outcomes, they are operationally considered geriatric conditions and named, respectively, osteoporosis and sarcopenia. Osteoporosis and sarcopenia share many of the same risk factors and both directly or indirectly cause higher risk of mobility limitations, falls, fractures and disability in activities of daily living. This is not surprising since bones adapt their morphology and strength to the long-term loads exerted by muscle during anti-gravitational and physical activities. Non-mechanical systemic and local factors also modulate the mechanostat effect of muscle on bone by affecting the bidirectional osteocyte-muscle crosstalk, but the specific pathways that regulate these homeostatic mechanisms are not fully understood. More research is required to reach a consensus on cut points in bone and muscle parameters that identify individuals at high risk for adverse health outcomes, including falls, fractures and disability. A better understanding of the muscle-bone physiological interaction may help to develop preventive strategies that reduce the burden of musculoskeletal diseases, the consequent disability in older persons and to limit the financial burden associated with such conditions. In this review, we summarize age-related bone-muscle changes focusing on the biomechanical and homeostatic mechanisms that explain bone-muscle interaction and we speculate about possible pathological events that occur when these mechanisms become impaired. We also report some recent definitions of osteoporosis and sarcopenia that have emerged in the literature and their implications in clinical practice. Finally, we outline the current evidence for the efficacy of available anti-osteoporotic and proposed antisarcopenic interventions in older persons.

KW - Aging

KW - Bone-muscle

KW - Disability

KW - Osteoporosis

KW - Sarcopenia

UR - http://www.scopus.com/inward/record.url?scp=84903710272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903710272&partnerID=8YFLogxK

U2 - 10.2174/13816128113196660690

DO - 10.2174/13816128113196660690

M3 - Article

C2 - 24050165

AN - SCOPUS:84903710272

VL - 20

SP - 3178

EP - 3197

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 19

ER -